Investors
As an investment > Strategy
Strategy
Strategy period 2024–2026
Our updated growth strategy keeps focusing on the eye care market, aiming to improve clinical diagnostics' quality through specific product innovations. Moreover, the objective is to streamline clinical care pathways via connected and predictive eye care solutions. To accomplish these goals, we enhance our customer-centric approach within operations and sales while developing further our people and culture as fundamental strengths. As a part of the strategy work, we have reviewed our ESG priorities and KPIs, establishing targets for the forthcoming years centered on creating value for stakeholders, society, people, and the planet.
The cornerstones of the updated strategy for 2024–2026 are:
Improve the quality of clinical diagnostics with targeted product innovations
Optimize clinical care pathways with connected and predictive solutions
Enhance customer focus in operations & sales
Continue to develop People & Culture as a foundational strength
Continue sustainable and profitable growth
Competitive advantages
Knowledge and people
Knowledge of the industry and global markets
Distribution channels
World-class quality products and processes
Technology
Research and development
Steady cash flow from sensor sales
Utilizing IP-protected Finnish inventions
Brand
- Strong and respected iCare brand
Production
- Volume flexible production model
Financial position strong
Profitability and balance sheet
Shareholder value
Growth drivers
Health care facing unprecedented global challenges
The global megatrends are providing us long term eye care market growth opportunities. In our view the demand for global eye care is increasing due to the aging and growing population, along with changing lifestyles. Comprehensive eye care delivery systems are becoming more important due to the increased system costs and resource shortages. Furthermore, the demand for telehealth and remote monitoring across markets is continuing to increase also due to the COVID-19 pandemic.
Global trends support our growth:
Aging populations with lifestyle-related diseases
Advancement in ophthalmic treatment
Insufficient eye care workforces
Changing healthcare landscape
.jpg)
Revenio Group Oyj | Äyritie 22 | 01510 Vantaa